Chris Cline
Director of Finance/CFO at TRAVERE THERAPEUTICS, INC.
Net worth: 381 876 $ as of 2024-04-29
Profile
Chris Cline is currently a Member at the National Investor Relations Institute.
He is also currently serving as the Chief Financial Officer at Travere Therapeutics, Inc. since 2014.
Mr. Cline completed his undergraduate degree at Williams College of Business.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-04-10 | 70,849 ( 0.09% ) | 381 876 $ | 2024-04-29 |
Chris Cline active positions
Companies | Position | Start |
---|---|---|
TRAVERE THERAPEUTICS, INC. | Director of Finance/CFO | 2022-08-30 |
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Corporate Officer/Principal | - |
Training of Chris Cline
Williams College of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
TRAVERE THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
National Investor Relations Institute
National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Commercial Services |
- Stock Market
- Insiders
- Chris Cline